Nasdaq · Healthcare
DENTSPLY SIRONA Inc. (XRAY)
As-reported financials and recent SEC filings for DENTSPLY SIRONA Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$3.68B
Net income
$-598.0M
Net margin
-16.3%
Diluted EPS
$-3.00
ROE
-44.6%
P/E (TTM)
—
Market cap
$2.21B
Debt / equity
1.5×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.68B | $3.79B | $3.96B | $3.92B | $4.23B |
| Gross profit | $1.84B | $1.96B | $2.09B | $2.13B | $2.35B |
| Operating income | $-422.0M | $-879.0M | $-85.0M | $-937.0M | $608.0M |
| Net income | $-598.0M | $-910.0M | $-132.0M | $-950.0M | $411.0M |
| Diluted EPS | $-3.00 | $-4.48 | $-0.62 | $-4.41 | $1.87 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
S-82026-06-26
View on EDGAR →4/A2026-06-18
View on EDGAR →32026-06-18
View on EDGAR →42026-06-16
View on EDGAR →42026-06-15
View on EDGAR →42026-06-15
View on EDGAR →42026-06-15
View on EDGAR →42026-06-15
View on EDGAR →Go deeper on XRAY
Search DENTSPLY SIRONA Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.